166 related articles for article (PubMed ID: 24438666)
1. [Involvement of pharmacists in systems for supervising off-label medications: example of the CAMTEA system for the prescription of baclofen in alcohol use disorder in Northern France].
Auffret M; Rolland B; Deheul S; Lecomte L; Cottencin O; Bordet R; Gautier S;
Ann Pharm Fr; 2014 Jan; 72(1):28-32. PubMed ID: 24438666
[TBL] [Abstract][Full Text] [Related]
2. [Temporary recommendation for use on off-label baclofen: viewpoint of Prescribers of the CAMTEA system].
Rolland B; Deheul S; Danel T; Bence C; Blanquart MC; Bonord A; Semal R; Briand T; Sochala M; Dubocage C; Dupriez F; Duquesne D; Gibour B; Loosfeld X; Henebelle D; Henon M; Vernalde E; Matton C; Bacquet JE; Molmy L; Sarasy F; Simioni N; Richez C; Gentil-Spinosi L; Vosgien V; Yguel J; Ledent T; Auffret M; Wilquin M; Ziolkowski D; Sochala M; Gautier S; Bordet R; Cottencin O;
Therapie; 2015; 70(2):235-8. PubMed ID: 25487850
[TBL] [Abstract][Full Text] [Related]
3. On-the-ground application of the 'temporary recommendation for use' regulatory measure on off-label use of baclofen for alcohol dependence in France: a regional survey of community pharmacies.
Auffret M; Rolland B; Caous AS; Gaboriau L; Deheul S; Bordet R; Gautier S
Fundam Clin Pharmacol; 2018 Apr; 32(2):234-238. PubMed ID: 29143356
[TBL] [Abstract][Full Text] [Related]
4. [Baclofen and liver cirrhosis: literature review and safety precautions implemented within the system CAMTEA].
Rolland B; Deheul S; Louvet A; Gautier S; Cottencin O; Bordet R;
Therapie; 2014; 69(2):143-7. PubMed ID: 24926632
[TBL] [Abstract][Full Text] [Related]
5. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
[TBL] [Abstract][Full Text] [Related]
6. Attitudes of community pharmacists to off-label prescribing of baclofen in Northern France.
Auffret M; Rolland B; Caous AS; Deheul S; Béné J; Cottencin O; Bordet R; Gautier S
Int J Clin Pharm; 2015 Apr; 37(2):296-9. PubMed ID: 25666941
[TBL] [Abstract][Full Text] [Related]
7. [A system of prescriptions without drug approval: example of baclofen].
Rolland B; Deheul S; Danel T; Bordet R; Cottencin O
Therapie; 2010; 65(6):511-8. PubMed ID: 21176757
[TBL] [Abstract][Full Text] [Related]
8. Off-label baclofen prescribing practices among French alcohol specialists: results of a national online survey.
Rolland B; Paille F; Fleury B; Cottencin O; Benyamina A; Aubin HJ
PLoS One; 2014; 9(6):e98062. PubMed ID: 24887094
[TBL] [Abstract][Full Text] [Related]
9. A capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in France.
Auffret M; Rolland B; Béhal H; Labreuche J; Jouanjus E; Bordet R; Gautier S
Therapie; 2019 Dec; 74(6):645-650. PubMed ID: 31277890
[TBL] [Abstract][Full Text] [Related]
10. Comment on: "Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France".
Braillon A
Drug Saf; 2017 Apr; 40(4):359-360. PubMed ID: 28185069
[No Abstract] [Full Text] [Related]
11. Authors' Reply to Alain Braillon's Comment on "Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: An example with baclofen and alcohol dependence in France''.
Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
Drug Saf; 2017 Apr; 40(4):361-362. PubMed ID: 28188600
[No Abstract] [Full Text] [Related]
12. Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol.
Rolland B; Auffret M; Labreuche J; Lapeyre-Mestre M; Dib M; Kemkem A; Grit I; Drelon M; Duhamel A; Cabe N; Vabret F; Guillin O; Baguet A; Masquelier C; Dervaux A; Deheul S; Bordet R; Carton L; Cottencin O; Jardri R; Gautier S
Expert Opin Drug Saf; 2017 Feb; 16(2):125-132. PubMed ID: 27984918
[TBL] [Abstract][Full Text] [Related]
13. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
[TBL] [Abstract][Full Text] [Related]
14. Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment.
Rolland B; Auffret M; Franchitto N
Expert Opin Drug Saf; 2016 Jun; 15(6):747-51. PubMed ID: 26987987
[TBL] [Abstract][Full Text] [Related]
15. Death of an alcohol-dependent patient following intentional drug intoxication: implication of baclofen?
Pape E; Roman E; Scala-Bertola J; Thivilier C; Javot L; Saint-Marcoux F; Jouzeau JY; Gambier N
Eur Addict Res; 2014; 20(6):300-4. PubMed ID: 25300747
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.
Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
CNS Neurosci Ther; 2016 Jan; 22(1):25-37. PubMed ID: 26768685
[TBL] [Abstract][Full Text] [Related]
17. [Addictions, alcoholism and baclofen: latest French news].
Nau JY
Rev Med Suisse; 2014 Jun; 10(435):1366-7. PubMed ID: 25051604
[No Abstract] [Full Text] [Related]
18. Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates.
Gorsane MA; Kebir O; Hache G; Blecha L; Aubin HJ; Reynaud M; Benyamina A
Subst Abus; 2012; 33(4):336-49. PubMed ID: 22989277
[TBL] [Abstract][Full Text] [Related]
19. Baclofen for alcohol dependence in France: incidence of treated patients and prescription patterns--a cohort study.
Dupouy J; Fournier JP; Jouanjus É; Palmaro A; Poutrain JC; Oustric S; Lapeyre-Mestre M
Eur Neuropsychopharmacol; 2014 Feb; 24(2):192-9. PubMed ID: 24139234
[TBL] [Abstract][Full Text] [Related]
20. [Baclofen: Innovative treatment or French controversy?].
Smadja J; Paradis M
Rev Med Interne; 2015 Jan; 36(1):3-6. PubMed ID: 25175490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
